AstraZeneca Pharma India shares rise over 2% after CDSCO clears Imfinzi for new cancer use

July 2, 2025

AstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for specific endometrial cancer cases. This follows AstraZeneca’s strong Q4 earnings, with a significant jump in net profit and revenue. The company attributes this to its focus on innovation.

More To Explore

Aluminium prices at record highs: What’s driving the rally and what’s next?

Aluminium prices have surged to multi-year highs, driven by strong demand, supply constraints, and rising energy costs. Geopolitical tensions and declining inventories have added volatility

April 19, 2026

Market Trading Guide: Buy Shipping Corporation and Power Grid on Monday for short-term gains of up to 29%

Nifty extended gains for a second week, supported by buying in consumer and metal stocks, with analysts maintaining a positive outlook above key levels. Experts

April 19, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003